Loading
Latest filing published 30 Dec 2025 for Enveric Biosciences, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Joseph Edward Tucker is a declared insider of Enveric Biosciences, Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 16 September 2021 to 23 December 2025, the count stands at 9 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 30 December 2025, reports a share grant in Enveric Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 7 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations